Latest News | SII Doing Best to Ramp Up COVID-19 Vaccine Production, Says CEO
Get latest articles and stories on Latest News at LatestLY. Serum Institute of India (SII) is doing its best to ramp up the production of COVID-19 vaccine Covishield to cater todemand in the country, Adar Poonawalla said on Saturday.
New Delhi, May 15 (PTI) Serum Institute of India (SII) is doing its best to ramp up the production of COVID-19 vaccine Covishield to cater todemand in the country, Adar Poonawalla said on Saturday.
Responding to a tweet by JSW Group Chairman Sajjan Jindal, Poonawalla said the vaccine major is doing itsbest to introduce vaccines on priority for the Indian market.
"Yes@sajjanjindal, we at @SerumInstIndia are doing our best toramp up production & launch new vaccines on priority for India. We aregrateful for @TheJSWGroup efforts in trying to fulfill India'smedical oxygen needs as we stand together in this fight against this pandemic,"Poonawalla said in a tweet.
Earlier Sajjan Jindal hadtweeted while tagging SII, Poonawalla , Bharat Biotech and its ManagingDirector Krishna Ella: "The only way we can win the #FightAgainstCOVID19in India is to vaccinate everybody. Great to see @SerumInstIndia @adarpoonawalla and@BharatBiotech @krishnaella ramping up theircapacities.”
Both SII and Bharat Biotech are in theforefront of supplying COVID-19 vaccines in the country even as the second wave ofthe pandemic continues to ravage various states.
(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)